What is Exact Imaging?
Exact Imaging specializes in advanced medical imaging technology, specifically developing high-resolution micro-ultrasound systems. Its core offering, the ExactVu platform, is engineered to provide urologists with enhanced visualization for the detection of prostate cancer. By integrating sophisticated imaging capabilities with a robust intellectual property foundation, Exact Imaging aims to facilitate earlier and more accurate diagnoses, thereby improving patient outcomes. The company operates within the competitive medical device market, where innovation in diagnostic tools is crucial for addressing unmet clinical needs and advancing patient care standards.
How much funding has Exact Imaging raised?
Exact Imaging has raised a total of $37.2M across 4 funding rounds:
Series B
$6M
Series C
$16.1M
Other Financing Round
$5.1M
Other Financing Round
$10M
Series B (2014): $6M with participation from Veddis and iGan Partners
Series C (2017): $16.1M led by iGan Partners, Lumira Capital, PMV, and Vesalius Biocapital Partners
Other Financing Round (2021): $5.1M supported by Export Development Canada and BDC
Other Financing Round (2026): $10M featuring iGan Partners
Key Investors in Exact Imaging
iGan Partners
iGan Partners is a prominent healthcare-focused venture capital firm that invests across North America, supporting the commercialization and scaling of innovative healthcare solutions through smart capital and strategic support.
Lumira Capital
Lumira Capital is a venture capital firm that invests in innovative companies, likely focusing on sectors that align with Exact Imaging's technological advancements in medical devices and diagnostics.
PMV
PMV is a financial partner that supports businesses in achieving their growth ambitions through tailored financing solutions, potentially providing capital for Exact Imaging's expansion and operational scaling.
What's next for Exact Imaging?
With the recent major strategic investment, Exact Imaging is poised to accelerate its market penetration and further develop its technological offerings. The substantial capital raised suggests a focus on scaling operations, expanding its global sales and distribution networks, and potentially investing in further research and development to enhance its micro-ultrasound technology. This funding will likely enable Exact Imaging to solidify its position as a leader in urologic imaging and explore new applications for its innovative platform, driving forward the adoption of advanced diagnostic tools in healthcare.
See full Exact Imaging company page
